S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   276.59 (-0.22%)
AAPL   114.20 (-0.66%)
MSFT   207.40 (-0.97%)
FB   261.90 (+1.98%)
GOOGL   1,467.99 (+0.64%)
AMZN   3,149.65 (-0.77%)
TSLA   420.00 (-0.28%)
NVDA   530.47 (+1.74%)
BABA   277.30 (+0.47%)
CGC   14.50 (+2.04%)
GE   6.10 (-1.61%)
MU   51.90 (+4.38%)
AMD   82.20 (+3.42%)
T   28.30 (-0.28%)
F   6.61 (-1.20%)
ACB   4.67 (-2.30%)
GILD   62.09 (-1.21%)
NFLX   494.30 (+0.74%)
DIS   125.54 (-0.36%)
BA   164.20 (-1.13%)
BAC   23.82 (-1.12%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   276.59 (-0.22%)
AAPL   114.20 (-0.66%)
MSFT   207.40 (-0.97%)
FB   261.90 (+1.98%)
GOOGL   1,467.99 (+0.64%)
AMZN   3,149.65 (-0.77%)
TSLA   420.00 (-0.28%)
NVDA   530.47 (+1.74%)
BABA   277.30 (+0.47%)
CGC   14.50 (+2.04%)
GE   6.10 (-1.61%)
MU   51.90 (+4.38%)
AMD   82.20 (+3.42%)
T   28.30 (-0.28%)
F   6.61 (-1.20%)
ACB   4.67 (-2.30%)
GILD   62.09 (-1.21%)
NFLX   494.30 (+0.74%)
DIS   125.54 (-0.36%)
BA   164.20 (-1.13%)
BAC   23.82 (-1.12%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   276.59 (-0.22%)
AAPL   114.20 (-0.66%)
MSFT   207.40 (-0.97%)
FB   261.90 (+1.98%)
GOOGL   1,467.99 (+0.64%)
AMZN   3,149.65 (-0.77%)
TSLA   420.00 (-0.28%)
NVDA   530.47 (+1.74%)
BABA   277.30 (+0.47%)
CGC   14.50 (+2.04%)
GE   6.10 (-1.61%)
MU   51.90 (+4.38%)
AMD   82.20 (+3.42%)
T   28.30 (-0.28%)
F   6.61 (-1.20%)
ACB   4.67 (-2.30%)
GILD   62.09 (-1.21%)
NFLX   494.30 (+0.74%)
DIS   125.54 (-0.36%)
BA   164.20 (-1.13%)
BAC   23.82 (-1.12%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   276.59 (-0.22%)
AAPL   114.20 (-0.66%)
MSFT   207.40 (-0.97%)
FB   261.90 (+1.98%)
GOOGL   1,467.99 (+0.64%)
AMZN   3,149.65 (-0.77%)
TSLA   420.00 (-0.28%)
NVDA   530.47 (+1.74%)
BABA   277.30 (+0.47%)
CGC   14.50 (+2.04%)
GE   6.10 (-1.61%)
MU   51.90 (+4.38%)
AMD   82.20 (+3.42%)
T   28.30 (-0.28%)
F   6.61 (-1.20%)
ACB   4.67 (-2.30%)
GILD   62.09 (-1.21%)
NFLX   494.30 (+0.74%)
DIS   125.54 (-0.36%)
BA   164.20 (-1.13%)
BAC   23.82 (-1.12%)
Log in
NASDAQ:SRNE

Sorrento Therapeutics SEC Filings & 10K Form

$11.80
+1.65 (+16.26 %)
(As of 09/29/2020 04:35 PM ET)
Add
Compare
Today's Range
$10.45
Now: $11.80
$12.17
50-Day Range
$6.17
MA: $9.39
$18.82
52-Week Range
$1.39
Now: $11.80
$19.39
Volume2.35 million shs
Average Volume27.15 million shs
Market Capitalization$2.86 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.93

SEC Filings

Sorrento Therapeutics (NASDAQ:SRNE) SEC Filings

DateFilerForm TypeView
09/29/2020
5:02 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
3:15 PM
Sorrento Therapeutics (Filer)
Form DEFA14A
09/17/2020
5:02 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
5:03 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2020
8:10 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
4:11 PM
Sorrento Therapeutics (Filer)
Form DEF 14A
08/21/2020
4:26 PM
Sorrento Therapeutics (Filer)
Form PRE 14A
08/21/2020
3:48 PM
Asghar Najjam (Reporting)
Sorrento Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/18/2020
3:47 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
6:44 PM
Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
8:01 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2020
8:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2020
8:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
3:40 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
3:38 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:36 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
5:11 PM
Shao Jiong (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:10 PM
SHAH JAISIM (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:10 PM
Lemus David (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:09 PM
Lee Edgar (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:09 PM
Followwill Dorman (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:09 PM
Sorrento Therapeutics (Issuer)
Wu Yue Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:08 PM
Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:08 PM
Ji Henry (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:08 PM
Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
8:31 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
3:02 PM
Sorrento Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/27/2020
3:38 PM
Sorrento Therapeutics (Filer)
Form 424B5
04/27/2020
3:38 PM
Sorrento Therapeutics (Filer)
Form 424B5
04/27/2020
3:37 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
5:03 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2020
11:15 PM
Sorrento Therapeutics (Filer)
Form EFFECT
03/20/2020
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
3:41 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
12:58 PM
Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
8:57 PM
Sorrento Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
5:04 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
5:05 AM
Ally Bridge Group Capital Partners II, L.P. (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
02/10/2020
3:46 PM
Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
02/10/2020
3:45 PM
China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
01/29/2020
11:15 PM
Sorrento Therapeutics (Filer)
Form EFFECT
01/29/2020
3:45 PM
Sorrento Therapeutics (Filer)
Form 424B3
01/27/2020
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
3:40 PM
Sorrento Therapeutics (Filer)
Form S-3/A
01/23/2020
11:15 PM
Sorrento Therapeutics (Filer)
Form EFFECT
01/22/2020
8:48 PM
Sorrento Therapeutics (Filer)
Form S-3/A
01/17/2020
4:08 PM
Sorrento Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/17/2020
3:17 PM
Sorrento Therapeutics (Filer)
Form S-3/A
01/10/2020
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
4:02 PM
Sorrento Therapeutics (Filer)
Form S-3/A
12/18/2019
4:56 PM
Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
4:51 PM
Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2019
4:25 PM
Sorrento Therapeutics (Filer)
Form S-3/A
12/11/2019
4:08 PM
Lee Edgar (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
4:06 PM
Lee Edgar (Reporting)
Sorrento Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
7:03 PM
Sorrento Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2019
3:41 PM
Sorrento Therapeutics (Filer)
Form CT ORDER
10/09/2019
10:46 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:18 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:15 PM
Sorrento Therapeutics (Filer)
Form 424B5
10/01/2019
3:32 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
3:28 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
3:26 PM
Sorrento Therapeutics (Filer)
Form 424B5
10/01/2019
1:23 PM
Sorrento Therapeutics (Filer)
Form CT ORDER
09/25/2019
4:31 PM
OAKTREE CAPITAL MANAGEMENT LP (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
09/23/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
5:06 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
4:19 PM
Sorrento Therapeutics (Filer)
Form DEF 14A
08/14/2019
12:39 PM
Sorrento Therapeutics (Filer)
Form CT ORDER
08/12/2019
9:10 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
9:07 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:49 PM
Sorrento Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
3:49 PM
Sorrento Therapeutics (Filer)
Form PRE 14A
07/02/2019
11:52 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
11:15 PM
Sorrento Therapeutics (Filer)
Form EFFECT
07/01/2019
3:53 PM
Sorrento Therapeutics (Filer)
Form 424B3
06/28/2019
4:20 PM
Sorrento Therapeutics (Filer)
Form 424B5
06/28/2019
4:17 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
5:06 AM
Sorrento Therapeutics (Subject)
Form FWP
06/28/2019
5:06 AM
Sorrento Therapeutics (Filer)
Form 424B5
06/20/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:40 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:28 PM
Sorrento Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/17/2019
8:22 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
3:46 PM
Sorrento Therapeutics (Filer)
Form CT ORDER
06/05/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
4:07 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
4:00 PM
Sorrento Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2019
9:41 AM
Sorrento Therapeutics (Filer)
Form CT ORDER
05/13/2019
3:02 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
3:01 PM
Sorrento Therapeutics (Filer)
Form NT 10-Q
05/09/2019
4:14 PM
Opko Health, Inc. (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13D
05/07/2019
11:15 PM
Sorrento Therapeutics (Filer)
Form EFFECT
05/07/2019
3:54 PM
Sorrento Therapeutics (Filer)
Form 424B3
This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.